Seven-day continuous abstinence rate from smoking at 1, 2, or 3 years after the use of varenicline.

about

Seven-day continuous abstinence rate from smoking at 1, 2, or 3 years after the use of varenicline.

Item

http://www.wikidata.org/entity/Q39019456

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Seven-day continuous abstinenc ...... after the use of varenicline.

@en

Seven-day continuous abstinenc ...... after the use of varenicline.

@nl

type

Item

label

Seven-day continuous abstinenc ...... after the use of varenicline.

@en

Seven-day continuous abstinenc ...... after the use of varenicline.

@nl

prefLabel

Seven-day continuous abstinenc ...... after the use of varenicline.

@en

Seven-day continuous abstinenc ...... after the use of varenicline.

@nl

P1476

Seven-day continuous abstinenc ...... after the use of varenicline.

@en

P2093

Byoung Whui Choi

http://www.w3.org/2001/XMLSchema#string

Eun Hye Park

http://www.w3.org/2001/XMLSchema#string

In Won Park

http://www.w3.org/2001/XMLSchema#string

Jae Chol Choi

http://www.w3.org/2001/XMLSchema#string

Jae Woo Jung

http://www.w3.org/2001/XMLSchema#string

Jae Yeol Kim

http://www.w3.org/2001/XMLSchema#string

Jin Se Kim

http://www.w3.org/2001/XMLSchema#string

Jong Wook Shin

http://www.w3.org/2001/XMLSchema#string

Joo Young Lee

http://www.w3.org/2001/XMLSchema#string

Ju Young Jang

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotine receptor partial agonists for smoking cessation

Relapse prevention interventions for smoking cessation

How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray.

Clinical practice. Treatment of tobacco use and dependence.

Varenicline for tobacco dependence.

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic.

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan.

P304

92-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4046/TRD.2015.78.2.92

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274721863

http://www.w3.org/2001/XMLSchema#string

P698

25861342

http://www.w3.org/2001/XMLSchema#string

P932

4388906

http://www.w3.org/2001/XMLSchema#string